190 related articles for article (PubMed ID: 27074708)
1. Signal transducer and activator of transcription STAT5 is recruited to c-Myc super-enhancer.
Pinz S; Unser S; Rascle A
BMC Mol Biol; 2016 Apr; 17():10. PubMed ID: 27074708
[TBL] [Abstract][Full Text] [Related]
2. Deacetylase inhibitors repress STAT5-mediated transcription by interfering with bromodomain and extra-terminal (BET) protein function.
Pinz S; Unser S; Buob D; Fischer P; Jobst B; Rascle A
Nucleic Acids Res; 2015 Apr; 43(7):3524-45. PubMed ID: 25769527
[TBL] [Abstract][Full Text] [Related]
3. Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.
Liu S; Walker SR; Nelson EA; Cerulli R; Xiang M; Toniolo PA; Qi J; Stone RM; Wadleigh M; Bradner JE; Frank DA
Mol Cancer Ther; 2014 May; 13(5):1194-205. PubMed ID: 24435449
[TBL] [Abstract][Full Text] [Related]
4. The natural chemopreventive agent sulforaphane inhibits STAT5 activity.
Pinz S; Unser S; Rascle A
PLoS One; 2014; 9(6):e99391. PubMed ID: 24910998
[TBL] [Abstract][Full Text] [Related]
5. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.
Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L
Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994
[TBL] [Abstract][Full Text] [Related]
6. JQ1 affects BRD2-dependent and independent transcription regulation without disrupting H4-hyperacetylated chromatin states.
Handoko L; Kaczkowski B; Hon CC; Lizio M; Wakamori M; Matsuda T; Ito T; Jeyamohan P; Sato Y; Sakamoto K; Yokoyama S; Kimura H; Minoda A; Umehara T
Epigenetics; 2018; 13(4):410-431. PubMed ID: 30080437
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cis-regulatory elements of the c-myc promoter responding to human GM-CSF or mouse interleukin 3 in mouse proB cell line BA/F3 cells expressing the human GM-CSF receptor.
Watanabe S; Ishida S; Koike K; Arai K
Mol Biol Cell; 1995 Jun; 6(6):627-36. PubMed ID: 7579683
[TBL] [Abstract][Full Text] [Related]
8. The synthetic α-bromo-2',3,4,4'-tetramethoxychalcone (α-Br-TMC) inhibits the JAK/STAT signaling pathway.
Pinz S; Unser S; Brueggemann S; Besl E; Al-Rifai N; Petkes H; Amslinger S; Rascle A
PLoS One; 2014; 9(3):e90275. PubMed ID: 24595334
[TBL] [Abstract][Full Text] [Related]
9. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells.
Nosaka T; Kawashima T; Misawa K; Ikuta K; Mui AL; Kitamura T
EMBO J; 1999 Sep; 18(17):4754-65. PubMed ID: 10469654
[TBL] [Abstract][Full Text] [Related]
10. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.
Yashiro-Ohtani Y; Wang H; Zang C; Arnett KL; Bailis W; Ho Y; Knoechel B; Lanauze C; Louis L; Forsyth KS; Chen S; Chung Y; Schug J; Blobel GA; Liebhaber SA; Bernstein BE; Blacklow SC; Liu XS; Aster JC; Pear WS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E4946-53. PubMed ID: 25369933
[TBL] [Abstract][Full Text] [Related]
11. Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation.
Girardot M; Pecquet C; Chachoua I; Van Hees J; Guibert S; Ferrant A; Knoops L; Baxter EJ; Beer PA; Giraudier S; Moriggl R; Vainchenker W; Green AR; Constantinescu SN
Oncogene; 2015 Mar; 34(10):1323-32. PubMed ID: 24681953
[TBL] [Abstract][Full Text] [Related]
12. Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2.
Martino A; Holmes JH; Lord JD; Moon JJ; Nelson BH
J Immunol; 2001 Feb; 166(3):1723-9. PubMed ID: 11160217
[TBL] [Abstract][Full Text] [Related]
13. A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression.
Yochum GS; Cleland R; Goodman RH
Mol Cell Biol; 2008 Dec; 28(24):7368-79. PubMed ID: 18852287
[TBL] [Abstract][Full Text] [Related]
14. Accessibility control of TCR Vγ region by STAT5.
Tani-ichi S; Lee HC; Ye SK; Ikuta K
Int Immunol; 2010 Aug; 22(8):693-703. PubMed ID: 20547543
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone stimulates transcription of the fibroblast growth factor 21 gene in the liver through the signal transducer and activator of transcription 5.
Yu J; Zhao L; Wang A; Eleswarapu S; Ge X; Chen D; Jiang H
Endocrinology; 2012 Feb; 153(2):750-8. PubMed ID: 22166977
[TBL] [Abstract][Full Text] [Related]
16. BET inhibition disrupts transcription but retains enhancer-promoter contact.
Crump NT; Ballabio E; Godfrey L; Thorne R; Repapi E; Kerry J; Tapia M; Hua P; Lagerholm C; Filippakopoulos P; Davies JOJ; Milne TA
Nat Commun; 2021 Jan; 12(1):223. PubMed ID: 33431820
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional activation of mouse TCR Jgamma4 germline promoter by STAT5.
Masui N; Tani-ichi S; Maki K; Ikuta K
Mol Immunol; 2008 Feb; 45(3):849-55. PubMed ID: 17664008
[TBL] [Abstract][Full Text] [Related]
18. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.
Dumon S; Santos SC; Debierre-Grockiego F; Gouilleux-Gruart V; Cocault L; Boucheron C; Mollat P; Gisselbrecht S; Gouilleux F
Oncogene; 1999 Jul; 18(29):4191-9. PubMed ID: 10435632
[TBL] [Abstract][Full Text] [Related]
19. Hierarchy within the mammary STAT5-driven Wap super-enhancer.
Shin HY; Willi M; HyunYoo K; Zeng X; Wang C; Metser G; Hennighausen L
Nat Genet; 2016 Aug; 48(8):904-911. PubMed ID: 27376239
[TBL] [Abstract][Full Text] [Related]
20. Integration of prolactin and glucocorticoid signaling at the beta-casein promoter and enhancer by ordered recruitment of specific transcription factors and chromatin modifiers.
Kabotyanski EB; Huetter M; Xian W; Rijnkels M; Rosen JM
Mol Endocrinol; 2006 Oct; 20(10):2355-68. PubMed ID: 16772529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
